ZA200610786B - Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions - Google Patents

Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions

Info

Publication number
ZA200610786B
ZA200610786B ZA200610786A ZA200610786A ZA200610786B ZA 200610786 B ZA200610786 B ZA 200610786B ZA 200610786 A ZA200610786 A ZA 200610786A ZA 200610786 A ZA200610786 A ZA 200610786A ZA 200610786 B ZA200610786 B ZA 200610786B
Authority
ZA
South Africa
Prior art keywords
modulators
diabetes
peptide
treatment
related conditions
Prior art date
Application number
ZA200610786A
Inventor
William R Ewing
Richard B Sulsky
Ving G Lee
Rogelio L Martinez
Mapelli Claudio
Tasir S Haque
Riexinger Douglas James
Zhu Yeheng
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ZA200610786B publication Critical patent/ZA200610786B/en

Links

ZA200610786A 2004-07-02 2006-12-20 Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions ZA200610786B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58535804P 2004-07-02 2004-07-02

Publications (1)

Publication Number Publication Date
ZA200610786B true ZA200610786B (en) 2008-12-31

Family

ID=38698080

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200610786A ZA200610786B (en) 2004-07-02 2006-12-20 Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions

Country Status (2)

Country Link
CN (1) CN101010339B (en)
ZA (1) ZA200610786B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2821886A1 (en) 2010-12-16 2012-06-21 Novo Nordisk A/S Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
EP2696687B1 (en) 2011-04-12 2016-10-26 Novo Nordisk A/S Double-acylated glp-1 derivatives
TR201903918T4 (en) 2012-03-22 2019-04-22 Novo Nordisk As Compositions containing a dispersing agent and their preparation.
CN111494323B (en) 2012-03-22 2023-03-28 诺和诺德股份有限公司 Compositions comprising delivery agents and preparation thereof
CN104203266B (en) 2012-03-22 2017-12-26 诺和诺德股份有限公司 The peptide combinations of GLP 1 and its preparation
JP6517690B2 (en) 2012-06-20 2019-05-22 ノヴォ ノルディスク アー／エス Tablet formulation containing peptide and delivery agent
TWI726889B (en) * 2015-06-10 2021-05-11 英商梅迪繆思有限公司 Protease-resistant lipidated peptides
CN117384274A (en) * 2016-12-09 2024-01-12 西兰制药公司 Acylated GLP-1/GLP-2 dual agonists
CA3087928A1 (en) 2018-02-02 2019-08-08 Novo Nordisk A/S Solid compositions comprising a glp-1 agonist, a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid and a lubricant

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ295768B6 (en) * 1998-12-07 2005-10-12 Societe De Conseils De Recherches Et D'application Analogues of GLP-1 having beta-alanine in position 35, their use and pharmaceutical compositions containing thereof

Also Published As

Publication number Publication date
CN101010339A (en) 2007-08-01
CN101010339B (en) 2011-11-09

Similar Documents

Publication Publication Date Title
IL180434A0 (en) Human glucagon - like - peptide - 1 modulators and their use in the treatment of diabetes and related conditions
HUP0700151A2 (en) Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
ZA200610786B (en) Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions
HUS2200006I1 (en) Novel ligands that modulate rar receptors and use thereof in human medicine and in cosmetics
DK3524261T5 (en) EXENDIN FOR USE IN THE TREATMENT OF DIABETES AND REDUCTION OF BODY WEIGHT
IL190733A0 (en) Methods and compositions for use in treatment of patients with autoantibody positive diseases
IL178012A0 (en) Diphenyl-indol-2-on compounds and their use in the treatment of cancer
ZA200808699B (en) Light emitting device for use in therapeutic and/or cosmetic treatment
PL3542869T3 (en) Disposable sleep and breathing monitor
EP1789109A4 (en) Dialysis implant and methods of use
EP1814909A4 (en) Use of aimp2dx2 for the diagnosis and treatment of cancer
EP2097107A4 (en) Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
PL1831149T3 (en) Novel ligands that modulate rar receptors and use thereof in human medicine and in cosmetics
EP1768583A4 (en) Electro-stimulation and medical delivery device
AU2003202075A1 (en) Modulator of the notch signalling pathway and use thereof in medical treatment
GB0523576D0 (en) Drug composition and its use in therapy
ZA200710800B (en) Melthod and apparatus for the non-invasive sensing of glucose in a human subject
AU2003226537A8 (en) Modulators of the notch signalling pathway and uses thereof in medical treatment
GB0420734D0 (en) Improvements in or relating to the therapeutic use of radiation and apparatus therefor
IL201426A0 (en) Drug combination and its use in the treatment of muscle loss
AU2003227944A1 (en) Ddah modulators in the treatment of pain
EP1733045A4 (en) Design and therapeutic use of adpase enhanced apyrases
EP1773882A4 (en) Diagnosis and treatment of siglec-6 associated diseases
AU2003245858A8 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
AU2003243405A1 (en) Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain